Acute-On-Chronic Liver Failure In Cirrhotic Patients
1 other identifier
observational
109
1 country
1
Brief Summary
Cirrhosis is a condition characterized by diffuse fibrosis, severe disruption of the intrahepatic arterial and venous flow, portal hypertension and, ultimately, liver cell failure. Traditionally, cirrhosis has been dichotomised in compensated and decompensated, and the transition to decompensated cirrhosis happens when any of the following hallmarks occurs: presence of ascites, variceal haemorrhage and/ or hepatic encephalopathy (HE) . In Egypt, HCV is the main cause of liver cirrhosis followed by HBV
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedMay 16, 2022
May 1, 2022
11 months
March 1, 2021
May 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Predictors of 28 day mortality rate in acute on chronic liver failure patients. with acute on top of chronic liver failure
It will be determined by univariate and multivariate analysis.
4 weeks from start point.
Secondary Outcomes (2)
Triggers of development of ACLF .
4 weeks from start point.
Types and numbers of organ failures in patients with ACLF.
4 weeks from start point
Eligibility Criteria
Cirrhotic patients whether compensated or decompensated with an acute decompensation of cirrhosis which is defined by the recent development of ascites, encephalopathy, GI haemorrhage, bacterial infection, or any combination of these
You may qualify if:
- Cirrhotic patients whether compensated or decompensated with an acute decompensation of cirrhosis which is defined by the recent development of ascites, encephalopathy, GI haemorrhage, bacterial infection, or any combination of these
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident in Tropical Medicine and Gastroenterology Department
Study Record Dates
First Submitted
March 1, 2021
First Posted
March 10, 2021
Study Start
March 1, 2021
Primary Completion
February 1, 2022
Study Completion
February 1, 2022
Last Updated
May 16, 2022
Record last verified: 2022-05